Publications in Immunogenomics

Filter publications display:

Publication Theme:   Publication Year:   Impact Factor:   

Genes to drugs in RA
May 2013

Human genetics in rheumatoid arthritis guides of high-throughput drug screen of the CD40 signaling pathway, Li G, Diogo D, Wu D, Spoonamore J, Dancik V, Franke F, Kurreeman F, Rossin EJ, Duclos G, Hartland C, Zhou X, Li K, Liu J, De Jager PL, Siminovitch KA, Zhernakova A, Raychaudhuri S, Bowes J, Eyre S, Padyukov L, Gregersen PK, Worthington J, Rheumatoid Arthritis Consortium International (RACI), Gupta N, Clemons PA, Stahl E, Tolliday N, Plenge RM. PLoS Genetics. 2013 May, in progress.

We demonstrate how to leverage human genetics for drug discovery.  Genetics of risk of RA points to a pathway (CD40-CD40L signaling) and a HTS assay (NF-kB luciferase-reporter in a B cell line), which was used in a pilot small molecule drug screen at the Broad Institute.

View article PDF

autoantigen discovery with PhIP-seq
March 2013

PhIP-seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis, Larman HB, Laserson U, Querol L, Verhaeghen K, Solimini NL, Xu GJ, Klarenbeek PL, Church GM, Hafler DA, Plenge RM, Nigrovic PA, De Jager PL, Weets I, Martens GA, O’Connor KC, Elledge SJ. J Autoimmun. 2013 Mar 13. [Epub ahead of print] PMID: 23497938

In collaboration with the Elledge lab, we performed a genome-wide search for autoantigens in patients with autoimmune disease.

View article PDF

Functional studies of CD40 polymorphism
September 2008

A Novel Polymorphism of the Human CD40 Receptor with Enhanced Function. Peters AL, Plenge RM, Graham RR, Altshuler DM, Moser KL, Gaffney PM, and Bishop GA. Blood 2008 Sep 1;112(5):1863-71. PMID: 18591382

We examined the functional consequences of a CD40 polymorphism present at high-frequency among individuals of Native American ancestry.

View article PDF